Galaxy Therapeutics Secures CE Mark for SEAL System
Milpitas, California, August 4, 2026 Galaxy Therapeutics has announced that its SEAL™ Embolization System has received CE Mark certification...
Europe
Advertisement
4Moving Biotech Targets Synovitis with Intra-Articular GLP-1 Therapy
LILLE & PARIS, France, Aug. 4, 2026 4Moving Biotech (4MB) announced the completion of patient enrollment in the Phase...
Pfizer and BioNTech Win EU Approval for XFG COVID-19 Vaccine
NEW YORK and MAINZ, Germany, July 29, 2026 Pfizer Inc. and BioNTech SE announced that the European Commission (EC)...
SpinaFX Earns CE Mark for Triojection Spine System
TORONTO, July 16, 2026 SpinaFX Medical Inc. has achieved a significant regulatory milestone with the Medical Device Regulation (MDR)...
Insulet Expands Omnipod 5 Diabetes Care in Spain
ACTON, Mass., July 6, 2026 Insulet Corporation announced the commercial launch of its Omnipod® 5 Automated Insulin Delivery System...
Advertisements
Lilly Jaypirca CHMP Backs EU Approval for CLL Treatment
INDIANAPOLIS, June 26, 2026 Eli Lilly and Company announced that the European Medicines Agency’s Committee for Medicinal Products for...
MaaT Pharma to Seek EMA Re-Examination for Xervyteg After CHMP Rejection
LYON, France, June 26, 2026 MaaT Pharma announced plans to request a re-examination of the European Medicines Agency (EMA)...
Private Equity Firm GTCR to Acquire Zentiva from Advent, Expanding Pharma Reach
Prague, Czech Republic; London, UK; Chicago, US – September 11, 2025 – Zentiva, a leading European generics pharmaceutical company,...
PharmaResearch and Laboratoires VIVACY Forge Strategic Alliance to Distribute REJURAN Across Europe
PharmaResearch, a regenerative medicine company headquartered in South Korea, has entered a strategic distribution partnership with France-based Laboratoires VIVACY,...
Advertisement
